NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Travere Therapeutics, Inc. ("Travere" or "the Company") (NASDAQ:TVTX). Investors who purchased Travere securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/TVTX. […]

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Apple Inc. ("Apple" or "the Company") (NASDAQ:AAPL). Investors who purchased Apple securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/AAPL. Investigation

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Meta Platforms, Inc. ("Meta" or "the Company") (NASDAQ:META). Investors who purchased Meta securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/META.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ:CAPR). Investors who purchased Capricor securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CAPR.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. ("GoHealth" or "the Company") (NASDAQ:GOCO). Investors who purchased GoHealth securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/GOCO. Investigation

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra" or "the Company") (NASDAQ:IART). Investors who purchased Integra securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site:

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of UroGen Pharma Ltd. ("UroGen" or "the Company") (NASDAQ:URGN). Investors who purchased UroGen securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/URGN.

Luton, Bedfordshire, United Kingdom, May 28, 2025 (GLOBE NEWSWIRE) — Market Overview The global smart predictive maintenance system market was valued at USD 5.2 billion in 2024 and is projected to reach USD 12.1 billion by 2034, expanding at a CAGR of 8.6% over the forecast period. This growth is driven by the increasing emphasis

Luton, Bedfordshire, United Kingdom, May 28, 2025 (GLOBE NEWSWIRE) — Market Overview The New Energy Vehicle (NEV) charging infrastructure market was valued at USD 16 billion in 2024 and is projected to reach USD 40 billion by 2034, expanding at a Compound Annual Growth Rate (CAGR) of 10.3% during the forecast period from 2025 to

Smart Predictive Maintenance System Market to Reach USD 12.1 Billion by 2034, Growing at 8.6% CAGR | Exactitude Consultancy Smart Predictive Maintenance System Market Report (2025-2034) GlobeNewswire May 28, 2025 Luton, Bedfordshire, United Kingdom, May 28, 2025 (GLOBE NEWSWIRE) — Market Overview The global smart predictive maintenance system market was valued at USD 5.2 billion